Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases

Kiora Pharmaceuticals, Inc. today announced its 2023 financial results and provided an update on its retinal disease development pipeline. The Company's major initiatives planned for 2024 are to...

Related Keywords

Brianm Strem , ,Nasdaq ,Linkedin ,California Newsfile Corp ,Kiora Pharmaceuticals Inc ,Twitter ,Kiora Pharmaceuticals ,Open Innovation ,Melissa Tosca ,Upcoming Milestones ,Orphan Drug Designations ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,